Introduction
============

Biofilms are associated with many infectious diseases in humans, including those occurring in the mouth ([@B34]). Early childhood caries (ECC) is a highly prevalent and difficult to treat biofilm-dependent disease, aﬄicting mostly underprivileged children worldwide and resulting in estimated annual expenditures of more than \$120 billion in the United States alone ([@B41]). Children with ECC are heavily infected with *Streptococcus mutans*, due in large part to protracted feeding of dietary sugars, such as sucrose ([@B9]; [@B58]; [@B59]), which leads to rapid accumulation of virulent biofilms characterized by an exopolysaccharides (EPS)-rich and highly acidic milieu that cause rampant destruction of the teeth ([@B72]; [@B32]).

*Streptococcus mutans* has long been regarded one of the key etiologic agents of ECC. *S. mutan*s possesses an exceptional ability to produce EPS using dietary sucrose via secreted exoenzymes termed glucosyltransferases (Gtfs), as well as being robustly acidogenic and acid-tolerant ([@B53]; [@B47]). In addition, *S. mutans* can efficiently cope with environmental stresses, which contributes to its ability to establish biofilms, to persist in the host, and to compete with other oral bacteria, particularly when conditions are conducive to initiation and progression of dental caries ([@B51]). However, *S. mutans* does not act alone in cariogenic biofilms, as additional organisms can also contribute to the initiation and/or progression of caries ([@B73]; [@B31]). Interestingly, results from several clinical studies reveal that *Candida albicans* is often detected in high numbers with *S. mutans* in biofilms from children with ECC ([@B22]; [@B63]; [@B80]; [@B46]; [@B62]).

*Candida albicans* is a commonly detected opportunistic fungus in the oral cavity ([@B28]). This organism interacts actively with commensal (viridans) streptococci and forms biofilms on acrylic and mucosal surfaces ([@B38]; [@B24]) to cause oral mucosal infections ([@B75]; [@B79]). In contrast, *C. albicans* does not bind well to *S. mutans*, nor does it colonize teeth effectively on its own ([@B39]; [@B30]). However, physical co-adhesion between *S. mutans* and *C. albicans* is markedly increased in the presence of sucrose ([@B13]; [@B30]; [@B55]; [@B27]). *S. mutans* Gtfs are capable of adhering to the surface of *C. albicans* and producing large amounts of EPS *in situ* using sucrose as substrate ([@B30]; [@B36]). In turn, the EPS on the fungal surface promotes adhesive interactions and cross-kingdom biofilm development with *S. mutans* ([@B27]).

In biofilms formed *in vitro*, the presence of *C. albicans* dramatically modifies the physical environment by increasing biomass and EPS production, enhancing biofilm accumulation and stability ([@B27]). Furthermore, *C. albicans* appears to activate *S. mutans* genes associated with biofilm formation and genetic competence ([@B27]; [@B71]). Importantly, using a rodent model of the disease and a diet rich in sucrose, enhanced levels of *S. mutans* in plaque-biofilms were associated with co-infection with *C. albicans*, which lead to onset of rampant caries similar to ECC ([@B27]). However, the molecular pathways by which such interactions stimulate *S. mutans* growth/metabolism, accumulation and virulence remain unclear.

Recently, RNA sequencing (RNA-Seq) combined with integrated gene network-pathway analysis greatly enhanced annotation/detection of bacterial transcripts and interpretation of genomic data ([@B20]; [@B83]), including in mixed-species biofilms ([@B26]). Here, we investigate the impact of the presence of *C. albicans* on the whole transcriptome of *S. mutans* using RNA-Seq and systems analysis. We first optimized enrichment of *S. mutans* mRNA from bacterial--fungal mixed total RNA, and then used RNA-Seq to transcription profile enriched mRNAs from single- and dual-species biofilm. The results show that the presence of *C. albicans* dramatically altered the transcriptome of *S. mutans*. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway impact analyses supported that co-culturing of *S. mutans* with *C. albicans* enhanced carbohydrate metabolism by *S. mutans*. Carbohydrate and metabolites analysis confirmed increased sugar utilization and elevated levels of formate in the supernatant fluid of dual-species biofilms. Moreover, we also found that *C. albicans* alters the transcription of two-component signal transduction systems that are important for fitness and sucrose-dependent biofilm formation. Conversely, mutacin (bacteriocin) production was down-regulated, which could influence the bacterial composition of the biofilms formed when *C. albicans* is present. Collectively, this study provides new insights into the effects of an opportunistic fungus (*C. albicans*) on the expression of genes that are integral to the persistence and virulence of *S. mutans* and how these inter-kingdom interactions may modulate the pathogenic potential of biofilms in ECC.

Materials and Methods {#s1}
=====================

Bacterial Strains and Growth Conditions
---------------------------------------

*Streptococcus mutans* strain UA159 serotype *c* \[a cariogenic bacterial pathogen (genome sequence accession number [AE014133](AE014133))\] and *C. albicans* SC5314 (genome sequence accession number [CP017630](CP017630)) were used in the present study to generate single and dual-species biofilm. Both strains were stored at -80°C in tryptic soy broth containing 20% glycerol.

Biofilm Preparation
-------------------

Biofilms were formed using a saliva-coated hydroxyapatite (sHA) disk model, as described elsewhere ([@B48]; [@B27]). Briefly, the hydroxyapatite disks (1.25 cm in diameter, surface area of 2.7 ± 0.2 cm^2^; Clarkson Chromatography Products, Inc., South Williamsport, PA, United States) were coated with filter-sterilized, clarified whole saliva and vertically suspended in 24-well plates using a custom-made wire disk holder ([@B48]). For single-species biofilms, each disk was inoculated with approximately 2 × 10^6^ CFU/mL of *S. mutans* in ultrafiltered (10-kDa cutoff; Millipore, Billerica, MA, United States) tryptone-yeast extract broth (UFTYE; 2.5% tryptone and 1.5% yeast extract, pH 7.0) containing 1% sucrose (37°C, 5% CO~2~). For dual-species biofilms, approximately 2 × 10^4^ CFU/mL of *C. albicans* containing predominantly yeast cell forms was also added to the inoculum; the composition of the microorganisms in the inoculum is similar to that found in saliva samples from children with ECC ([@B22]; [@B27]). During the first 18 h, the organisms were grown undisturbed so as to allow initial biofilm formation; the culture medium was then changed twice daily at 8 a.m. and 6 p.m. until the end of the experimental period (42 h).

RNA Extraction and Purification
-------------------------------

Biofilms were harvested after 42 h incubation. RNA was extracted and purified using protocols optimized for biofilms formed *in vitro* ([@B21]). Three separate biological replicates for each group (single and mixed-species) were performed. Briefly, disk sets were incubated in RNALater (Applied Biosystems/Ambion, Austin, TX, United States), then the biomass was removed from the sHA disks. RNAs were purified and treated with DNase on a column using the Qiagen RNeasy Mini kit (Qiagen, Valencia, CA, United States). The RNAs were then subjected to a second DNase I treatment with Turbo DNase (Applied Biosystems/Ambion) and were purified using the Qiagen RNeasy MinElute cleanup kit (Qiagen). RNAs were quantified using the NanoDrop ND-1000 spectrophotometer (Thermo Scientific/NanoDrop, Wilmington, DE, United States). RNA quality was evaluated using an Agilent 2100 bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, United States), and all RNAs used for downstream experiments were determined to have RNA integrity numbers (RIN) of 9.5 and above.

Bacterial mRNA Enrichment and RNA-Seq Performance
-------------------------------------------------

To deplete fungal total RNA, the MICROBEnrich^TM^ Kit (Ambion of Life Technologies, Grand Island, NY, United States) was used with modifications. Briefly, RNA was combined with binding buffer and capture oligonucleotide mix. The RNA mix was heated to 70°C for 10 min then incubated at 37°C for 1 h to hybridize to the capture oligos. The RNA/capture oligo mix was equilibrated with Oligo MagBeads and incubated at 37°C for 15 min. Tubes were placed on a magnet to separate the supernatant fluids containing the enriched bacterial total RNA from the Oligo MagBeads. The enriched bacterial RNA was purified and concentrated by ethanol precipitation. Ribo-Zero^TM^ rRNA Removal Kits for Gram-Positive Bacteria (Epicentre, Madison, WI, United States) and MICROBExpress^TM^ Kit (Ambion) were tested for their efficiency of depleting the bacterial ribosomal RNA according to the supplier's specifications. (1) RNA input amounts determined the amount of Ribo-Zero rRNA removal solution to add (10 μL rRNA removal solution for 2.5 to 5 μg, or 8 μL for \<2.5 μg total RNA per reaction). Samples in Ribo-Zero rRNA removal solution were incubated at 68°C for 10 min followed by a 15 min incubation at room temperature. To remove the hybridized rRNA molecules from the mRNA, the RNA/rRNA solution reactions were incubated with the prepared microsphere beads, mixed well and placed at room temperature for 10 min, then at 50°C for 10 min. The mRNAs were separated from the microspheres bound with rRNAs by a filter column provided in the kit. The final purification of eluted mRNA was performed by ethanol precipitation. (2) For MICROBExpress^TM^ Kit, RNA was mixed with binding buffer and capture oligonucleotide mix. The RNA mix was heated to 70°C for 10 min then incubated at 37°C for 15 min to hybridize the capture oligos. The RNA/capture oligo mix was equilibrated with Oligo MagBeads and incubated at 37°C for 15 min. Tubes were placed on a magnet to separate the supernates containing the enriched bacterial total RNA from the Oligo MagBeads. The enriched bacterial RNA was purified and concentrated by ethanol precipitation. The final quality of enriched bacterial mRNA samples was analyzed using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, United States). The efficiency of Ribo-Zero^TM^ rRNA Removal and MICROBExpress^TM^ Kits were compared and the results are included in the Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}. Based on experimental data, we selected MICROBEnrich + Ribo-Zero as an optimized method to enrich *S. mutans* mRNA from mixed bacterial--fungal RNA samples.

cDNA libraries were generated from the enriched mRNA samples using NEBNext Ultra directional RNA library prep kit for Illumina and NEBNext multiplex oligonucleotides for Illumina (New England BioLabs, Ipswich, MA, United States), following instructions from the supplier. RNA-Seq was performed on the NextSeq500 (75-bp single end reads) by the NextGen DNA Sequencing Core Laboratory of the Interdisciplinary Center for Biotechnology Research at the University of Florida (Gainesville, FL, United States). Read mapping was performed on a Galaxy server hosted by the high-performance research computing center at the University of Florida (HiPerGator2.0) using Map with Bowtie for Illumina (version 1.1.2). Reads were mapped to the *S. mutans* UA159 genome. Mapped reads were then counted using the Python script htseq-count ([@B7]).

Statistical Analysis of RNA-Seq Data
------------------------------------

Fold changes and significant differences in gene expression between growth conditions were calculated using the convergence of three separate approaches: DEseq, edgeR, and limma ([@B6]; [@B64]; [@B50]), as implemented in the R/Bioconductor package metaseqR ([@B56]). GO terms were assigned to genes using Blast2GO v.2.5.0 ([@B29]). Relative enrichment (overrepresentation) of GO terms for up-regulated genes compared to a background of GO terms for all genes was assessed using Fisher exact tests. The test was performed using the Gossip statistical package ([@B11]) implemented within Blast2GO. The false discovery rate (FDR) procedure of [@B8] was used to correct for multiple hypothesis testing (FDR = 0.05).

To gain further insights into the effects of co-cultivation of *C. albicans* on *S. mutans*, we performed a KEGG pathway impact analysis using the software package Pathway-Express as implemented in the R/Bioconductor package ROntoTools ([@B18]). A systems biology approach such as this has the advantage of being able to factor the complex interactions among genes. It combines evidence from traditional expression level data with information regarding the dynamics of gene--gene interaction and the relative position of the gene within a pathway. Positional information is important as the action of genes up-stream in a pathway can propagate further down-stream and amplify effects of changes in gene expression. By combining all evidence, pathway impact can be calculated. FDR procedure of [@B8] was again used to correct for multiple hypothesis testing (FDR = 0.05).

Data Validation
---------------

To validate the RNA-Seq data, quantitative real-time PCR (qRT-PCR) was employed to measure changes in the amount of mRNA of selected genes. The cDNA was synthesized from 1 μg of purified RNA with Bio-Rad iScript cDNA synthesis kit (Bio-Rad Laboratories, Inc., Hercules, CA, United States), and quantitative amplification condition using Bio-Rad iTaq Universal SYBR Green Supermix and Bio-Rad CFX96 system (Bio-Rad Laboratories, Inc.). Standard curves for each primer were used to determine the relative number of cDNA molecules, and relative expression was calculated by normalizing to the *gyrA* gene transcripts, which is a validated reference gene for normalization of qRT-PCR ([@B65]; [@B82]). The minimum information for publication of qRT-PCR experiments (MIQE) guidelines were followed for quality control of the data generated and for data analysis ([@B16]).

Carbohydrates and Metabolites Analyses
--------------------------------------

The biofilm and the respective surrounding culture medium were collected at 42 h, homogenized via sonication and centrifuged at 5,500 × *g* for 10 min at 4°C. The supernatant was filtered through 0.2 μm-pore-size membrane filter (ultra-low protein binding, surfactant-free cellulose acetate, Nalgene, Rochester, NY, United States). The amount of sucrose, glucose, and fructose in the supernatant were quantified using high-performance anion-exchange chromatography (HPAEC; Dionex, Sunnyvale, CA, United States) and the biofilm-derived metabolites were identified and quantified through ^1^H nuclear magnetic resonance (^1^H-NMR; Bruker Avance III HD NMR spectrometer, Bruker Biospin, Billerica, MA, United States) as described previously ([@B43]). The significance was determined by direct comparison with concentration in the blank (original UFTYE medium) and substrates and metabolites are characterized by the calculation of fold changes (log~2~) relative to the blank (UFTYE medium). The concentrations of glucose, fructose, formate, and lactate in the supernatant of single- and dual-species biofilms were subtracted with the values of blank. A pairwise comparison (non-parametric Mann--Whitney *U* test or parametric *t*-test) was performed using SPSS 18.0 software (IBM Co., Armonk, NY, United States). Differences are considered significant with ^∗^*P* \< 0.05 or *^∗∗∗^P* \< 0.001.

Results and Discussion
======================

Transcriptomic Changes of *S. mutans* within Mixed-Species Biofilms
-------------------------------------------------------------------

Results from previous studies have shown enhanced *S. mutans* growth and biofilm formation as well as alterations in gene expression when co-cultured with *C. albicans* in the presence of sucrose ([@B27]; [@B71]). However, whole bacterial transcriptome characterization of effects of the presence of *C. albicans* in the dual-species biofilm milieu in combination with gene network pathway analysis is needed to gain a comprehensive picture of the underlying molecular mechanisms. To achieve this, we used our extensively optimized RNA extraction and mRNA enrichment protocol. Total RNA was isolated either from *S. mutans* single-species or *S. mutans*--*C. albicans* co-cultivation biofilms, and prokaryotic mRNA was enriched as described above and in the Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}. A total of 587909293 reads were produced from the six samples. The sequence reads of all samples were deposited in the NCBI sequence read archive (SRA) as a study under the accession number of ([SRR5116699-5116704](SRR5116699-5116704)). We first applied Multi-Dimensional Scaling (MDS) to provide a visual representation of the transcriptomic similarities between dual- and single-species biofilms. Samples marked with distinct colors were projected to a two-dimensional space and clustered separately (**Figure [1A](#F1){ref-type="fig"}**), indicating high levels of correlation and reproducibility among samples, as well as distinctive transcriptome profiles from *S. mutans* in the presence or absence of *C. albicans.* Three statistical methods, including DEseq, edgeR, and limma, were used to pinpoint differentially expressed genes (DEGs) between groups.

![Overall transcriptomic changes of *S. mutans* within *S. mutans--C. albicans* dual biofilm. **(A)** Multi-Dimensional Scaling (MDS) plot based on Euclidean distances derived from a sample variance parameter, showing the level of correlation and reproducibility among samples. Red circles (D) show dual biofilm, whereas blue triangles (S) show single. Samples from single and dual biofilm group clustered together, respectively, indicating the different transcriptome pattern of *S. mutans* with and without *C. albicans*. **(B)** Plot showing fold change and levels of significance for differential expression for all genes.](fmicb-08-01036-g001){#F1}

Overall, 393 genes showed significant differences in expression between single and dual-species biofilm for all three statistical methods with log~2~ (fold change) \> 0.6 or \< -0.7 (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), accounting for ∼20% (393/2042) of the total genes annotated in *S. mutans* UA159. Among the DEGs, 134 were up-regulated, 259 were down-regulated, and about 40% (158/393 genes) were of unknown function or hypothetical. The genes encoding the four-enzyme pyruvate dehydrogenase complex \[*pdhD* (SMU_1424)-*pdhA* (SMU_1423)*-pdhB* (SMU_1422)*-pdhC* (SMU_1421)\] and *adhE* (SMU_148) showed the highest up-regulation in mixed-species biofilms (fold change \> 4.5, **Figure [1B](#F1){ref-type="fig"}**). All of these five genes are part of the pyruvate metabolism pathway, converting pyruvate to acetyl-CoA in cells growing in aerobic conditions. The gene (SMU_2133c) marked with a question mark in **Figure [1B](#F1){ref-type="fig"}** is not part of the pyruvate pathway and has an ambiguous annotation: hypothetical protein, transmembrane protein, or phage infection protein. Based on the RNA-seq data, we selected 10 DEGs (three down-regulated and seven up-regulated) showing a broad range of differential expression for validation by using qRT-PCR analysis. Consistent with the RNA-Seq data, the qPCR data showed significant differential expression of all genes tested (**Table [1](#T1){ref-type="table"}**) and a linear-correlation with RNA-seq data (*r*^2^ = 0.98). We noted that the level of differential expression of some genes (e.g., *gtfB, gtfC*) was not entirely similar to that reported in our previous work ([@B27]). Differences between the two studies may be due to several factors, including different RNA sources/preparation (total RNA vs. rRNA depleted/mRNA enriched) and algorithm/data analysis to calculate fold changes. Despite differences in the level of gene expression, both studies confirmed up-regulation of *gtfBC* in dual-species biofilm (vs. single-species *S. mutans* biofilm).

###### 

Validation of RNA-Seq data by qPCR.

  Gene        Fold change (dual/single)   
  ----------- --------------------------- -------------
  *comC*      0.46                        0.30 ± 0.03
  *luxS*      0.60                        0.60 ± 0.04
  *atpB*      0.62                        0.64 ± 0.03
  *hrcA*      1.57                        1.57 ± 0.09
  *SMU.104*   1.80                        1.77 ± 0.14
  *ciaR*      2.04                        2.06 ± 0.21
  *lacC*      2.25                        1.83 ± 0.09
  *gbpC*      2.26                        2.36 ± 0.16
  *adhE*      4.49                        3.90 ± 0.14
  *pdhA*      11.39                       8.12 ± 1.60

a

Changes in transcript levels were determined using

gyr

A as an internal control and qRT-PCR results are presented as averages ± standard deviations.

Gene Ontology terms were assigned to all genes in the *S. mutans* genome. We compared terms for the up- and down-regulated genes to a background of all terms to obtain an overall insight into the impact of *C. albicans* on *S. mutans* when growing together in dual-species biofilms. Forty-two GO terms were overrepresented (enriched) (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}): among them, 22 were involved with biological processes, of which 10 with up-regulated genes and 12 with down-regulated genes (**Table [2](#T2){ref-type="table"}**). Notably, all the GO terms for up-regulated genes belonged to the biological process domain and were involved in carbohydrate transport and metabolic/catabolic process. These findings are interesting since sugar catabolism is a key risk factor for dental caries ([@B67]), and are consistent with enhanced sugar utilization in dual-species biofilm (vs. single-species *S. mutans* biofilm) as determined by chromatographic analyses (**Figure [2A](#F2){ref-type="fig"}**). Since *Candida* is rather inefficient in metabolizing sucrose ([@B78]), *S. mutans* can cross-feed sucrose break-down products (glucose and fructose) to *C. albicans* ([@B71]; [@B43]). We observed that the concentrations of glucose and fructose in the supernatant of dual-species biofilm are significantly lower than those in single-species *S. mutans* biofilm (**Figure [2A-a2](#F2){ref-type="fig"}**; *P* \< 0.05). The data indicate that *S. mutans* co-cultured with *C. albicans* utilized most of the fermentable sugars, while also increasing the levels of formate (**Figure [2B](#F2){ref-type="fig"}**). Hence, once they are together within biofilm, these organisms may cooperate with each other for provision of sugar substrates and metabolites. Conversely, enhanced sugar utilization can also cause localized carbohydrate limitation in the presence of *Candida* that could influence the gene expression profile and the bacterial metabolic pathways.

###### 

GO terms for biological processes with up and down-regulated genes for *S. mutans* grown with *C. albicans.*

  Up regulated biological process           Down regulated biological process
  ----------------------------------------- --------------------------------------
  Disaccharide metabolic process            Translation
  Oligosaccharide metabolic process         Multi-organism process
  Cellular carbohydrate catabolic process   Cellular protein metabolic process
  Oligosaccharide catabolic process         Response to external biotic stimulus
  Disaccharide catabolic process            Response to other organism
  Phosphoenolpyruvate-dependent sugar       Response to biotic stimulus
  phosphotransferase system                 Defense response to other organism
  Lactose metabolic process                 Response to external stimulus
  Carbohydrate metabolic process            Defense response
  Carbohydrate transport                    Protein metabolic process
                                            Defense response to bacterium
                                            Response to bacterium

![The composition of extracellular carbohydrates and metabolites. **(A)** HPAEC chromatograms of selected carbohydrates profile **(a1)** and the concentrations of glucose and fructose as the main carbohydrates (sucrose is not detected in both supernatants) in biofilm-culture supernatants **(a2)**. In the box whisker plots, whiskers represent minimum and maximum, and the box represents the 25th and 75th percentiles (*n* = 3). ^∗^*P* \< 0.05. **(B)** Profiles of extracellular metabolites (e.g., organic acids, alcohols, sugar alcohols, amino acids) **(b1)** and the concentrations of formate and lactate (red arrowheads) as the main organic acids, which is associated with cariogenic properties of *S. mutans*, in biofilm-culture supernatants **(b2)**. Substrates and metabolites are characterized by the calculation of fold changes (log~2~) relative to the blank (fresh UFTYE medium). Data represent mean ± standard deviations (*n* = 3). ^∗∗∗^*P* \< 0.001.](fmicb-08-01036-g002){#F2}

We also performed a KEGG pathway impact analysis based on the sequencing data. The analysis detected eight KEGG pathways that were significantly impacted: pyruvate metabolism, galactose metabolism, butanoate metabolism, glycine, serine and threonine metabolism, propanoate metabolism, glyoxylate and dicarboxylate metabolism, oxidative phosphorylation, and amino sugar and nucleotide sugar metabolism (**Figure [3](#F3){ref-type="fig"}** and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). Highly consistent with GO analysis, most of the impacted pathways were involved in carbohydrates metabolism. The end products of sugar fermentation are energy generation and predominantly organic acids, which can provide advantages for *S. mutans* survival and growth, while acidification of the environment helps both *S. mutans* and *C. albicans* (highly acid-tolerant organisms) to outcompete beneficial commensal bacteria ([@B15]; [@B45]). This metabolic cooperation provides an effective mechanism that promotes co-existence while enhancing *S. mutans* accumulation ([@B27]; [@B43]). At the same time, the bacterial population is probably heterogeneous with respect to carbohydrate utilization, and the transcriptome pattern could be compartmentalized within the biofilm. It is apparent that when *S. mutans* and *C. albicans* are together within biofilms when conditions are conducive for ECC, the presence of *Candida* modulates carbohydrate utilization while also creating carbohydrate-limiting conditions, both of which can activate the PDH pathway.

![Plot showing result of a pathway impact analysis as implemented in Pathway-Express. The y-axis shows evidence for over-representation of differentially expressed genes in a pathway and the *x*-axis shows perturbation evidence (measured expression changes propagating across the pathway topology). A combination of the factors on each axis equates to the level of impact and the diagonal line represents a significance threshold (α = 0.05). After FDR correction, eight KEGG pathways (red dots) remained significant. Two pathways (pyruvate and galactose metabolism) at the extremes of the axes showed the most impact.](fmicb-08-01036-g003){#F3}

Co-culturing with *C. albicans* Modulates Carbohydrate Utilization by *S. mutans*
---------------------------------------------------------------------------------

The increased sugar metabolism can explain in part the increased carriage of *S. mutans* and *C. albicans* and enhanced virulence of plaque-biofilms *in vivo* ([@B27]). Sucrose, in particular, has long been considered the most cariogenic of all carbohydrates. This disaccharide serves as both a readily metabolizable carbon and energy source and as an essential substrate for the synthesis of the adhesive extracellular glucan matrix by *S. mutans*, which strengthens the interactions between *S. mutans* and *C. albicans* and augments the stability of biofilms containing these organisms ([@B30]; [@B27]). In addition to sucrose utilization extracellularly ([@B12]), *S. mutans* rapidly transports sucrose into the cell by the phosphoenolpyruvate:sugar phosphotransferase system (PTS) ([@B4]; [@B57]). Here, we observed that *scrA* (SMU_1841), *scrB* (SMU_1843), and *scrK* (SMU_1840) were significantly up-regulated in dual-species biofilms (vs. single species *S. mutans*; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). The *scr*A gene encodes a high-affinity sucrose PTS permease, EII^Scr^, that internalizes sucrose as sucrose-6-phosphate ([@B66]). The ScrB enzyme is a sucrose-6-PO~4~ hydrolase that produces glucose-6-PO~4~ and fructose (**Figure [4](#F4){ref-type="fig"}**). After phosphorylation of fructose to fructose-6-phosphate by a fructokinase (*scrK*), the phosphorylated products are channeled into the glycolytic pathway ([@B19]). Furthermore, *pttB* (SMU_2038), encoding a trehalose PTS permease, was also up-regulated in dual-species biofilms (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Notably, the trehalose-PTS (i.e., EII^Tre^), the primary transporter for trehalose ([@B60]), is also able to transport sucrose, as mutants derived from *S. mutans* UA159 that lacked ScrA could still internalize sucrose via the PTS if an intact EII^Tre^ was present ([@B81]). Besides the PTS, the multiple-sugar metabolism system (Msm) ([@B74]) and the maltose/maltodextrin ABC transporter ([@B42]) have been also implicated in sucrose uptake by *S. mutans*, albeit not nearly as effectively as the sucrose PTS. Still, both *malG* (SMU_1570) and *malF* (SMU_1569) encoding maltose/maltodextrin ABC transport permease, as well as *malX* (SMU_1568) encoding maltose/maltodextrin-binding protein were up-regulated in the presence of *C. albicans* (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

![KEGG galactose metabolism pathway map (smu:00052) for *S. mutans* UA159. *S. mutans* genes involved in the pathway are shown in green. Of these, eleven showed differential expression. The nine bordered in red were up-regulated and the one bordered in blue was down-regulated. Six of the seven genes comprising the galactose pathway for lactose catabolism (*lac*E, *lac*F, *lac*G, *lac*A, *lac*B, *lac*C, and *lac*D) were up-regulated, and two genes of Leloir pathway (*gal*K and *galT*) were up-regulated. Numbers inside boxes are enzyme commission numbers.](fmicb-08-01036-g004){#F4}

Genes for galactose metabolism by *S. mutans* were also up-regulated in the presence of *C. albicans*, which could simply reflect relief of catabolite repression. Another possible explanation is that *C. albicans* can produce galactose via up-regulation of its metabolic pathway by *N*-acetylglucosamine (GlcNAc) ([@B40]), which is a ubiquitous dietary sugar and also produced through bacterial biosynthesis ([@B57]). We found detectable amounts of GlcNAc in the supernatant of biofilm cultures of *S. mutans--C. albicans* \[∼20 μM; compared to *S. mutans* alone (∼10 μM) (data not shown)\], which may help to explain, at least in part this observation. *S. mutans* can metabolize galactose by two distinct pathways: the tagatose 6-phosphate pathway ([@B23]) and Leloir pathway ([@B5]). Previous studies have shown that *S. mutans* can efficiently metabolize when both the tagatose 6-phosphate pathway and Leloir pathways are functional, while the tagatose pathway is responsible predominantly for the utilization of the phosphorylated galactose moiety that comes from the breakdown of lactose 6-phosphate ([@B2]; [@B84]).

In *S. mutans*, the genes encoding the tagatose 6-phosphate pathway are arranged as part of the *lac* operon. When co-culturing with *C. albicans*, six of the seven genes comprising tagatose 6-phosphate pathway \[*lacE* (SMU_1491), *lacF* (SMU_1492), *lacA* (SMU_1496), *lacB* (SMU_1495), *lacC* (SMU_1494), and *lacD* (SMU_1493)\] were up-regulated (**Figure [4](#F4){ref-type="fig"}** and Supplementary Table [S4](#SM1){ref-type="supplementary-material"}), which are consistent with their sequential role in the galactose metabolism. The galactose moiety of lactose, and possibly galactose alone, can be transported and phosphorylated by a lactose-specific (LacEF) PTS. The resultant galactose 6-phosphate generated by an intracellular 6-phospho-β-galactosidase is converted into tagatose 6-phosphate, then to tagatose-1,6-bisphosphate, and then to glyceraldehyde 3-phosphate and dihydroxyacetone by the enzymes galactose-6-phosphate isomerase (*lacAB*), tagatose 6-phosphate kinase (*lacC*), and tagatose-1,6-bisphosphate aldolase (*lacD*), respectively ([@B2]). Furthermore, two genes of Leloir pathway \[*galK* (SMU_886) and *galT* (SMU_887)\] were also up-regulated (**Figure [4](#F4){ref-type="fig"}**), although the GalK pathway is minor and not as efficient as the tagatose pathway in *S. mutans* ([@B2]). In the Leloir pathway, galactose enters the cell via an unidentified permease, where it is phosphorylated by galactokinase (*galK*) to yield galactose 1-phosphate, which is then converted into glucose 1-phosphate by hexose1-phosphate uridyltransferase (*galT*) and UDP-glucose epimerase \[*galE* (SMU_888)\]. The resulting glucose 1-phosphate can enter the glycolytic pathway.

Pyruvate Metabolism of *S. mutans* in Dual-Species Biofilms
-----------------------------------------------------------

The transcriptomic data suggest that *C. albicans* promotes *S. mutans* sugar utilization, leading to induction and/or derepression of genes for multiple catabolic pathways via inputs from global and specific regulatory systems. Among them, pyruvate metabolism is an important mechanism for *S. mutans* survival and expression of virulence within cariogenic biofilms that balances the need for ATP with maintenance of NAD/NADH ratios and for carbon for amino acid biosynthesis ([@B44]). Our pathway impact analysis shows that the pyruvate metabolism is substantially altered when *S. mutans* is growing in the presence of *C. albicans*, compared to single-species biofilms of *S. mutans* (**Figures [1B](#F1){ref-type="fig"}, [5](#F5){ref-type="fig"}** and Supplementary Table [S4](#SM1){ref-type="supplementary-material"}). All the genes in the *pdh* operon (*pdhD--pdhA--pdhB--pdhC*), as well as *pfl*2 (SMU_493) encoding PFL (**Figure [5](#F5){ref-type="fig"}**) and *pfl*A (SMU_1692) encoding PFL activating enzyme (Supplementary Table [S4](#SM1){ref-type="supplementary-material"}) were up-regulated in dual-species biofilm (vs. single-species *S. mutans*). It is conceivable that pyruvate metabolism was different between single- and dual-biofilms since both the glucose and fructose from sucrose and galactose catabolism lead to pyruvate production.

![KEGG pyruvate metabolism pathway map (smu:00620) for *S. mutans* UA159. *S. mutans* genes involved in the pathway are shown in green. Of these, eight showed differential expression. The six bordered in red were up-regulated and the one bordered in blue was down-regulated. At the center of the pathway, showing strong up-regulation is the four-enzyme pyruvate dehydrogenase complex (*pdhD--pdhA--pdhB--pdhC*) (PDH).](fmicb-08-01036-g005){#F5}

Pyruvate sits at an intersection of key pathways of sugar metabolism, and is converted by (1) pyruvate dehydrogenase complex (PDHc) into acetyl-CoA and CO~2~, (2) pyruvate formate lyase (PFL) yielding acetyl-CoA and formate, and (3) lactate dehydrogenase (LDH) into lactate that can be further metabolized. PDH and PFL pathways are activated when carbohydrates are not present in excess, suggesting that at least some cells in the dual-species biofilm might experience limitation for carbohydrate (**Figure [2](#F2){ref-type="fig"}**). Both GO and KEGG results indicate *S. mutans* and *C. albicans* may be competing for the fermentable sugar available in the culture medium when grown together in biofilms, which could trigger derepression or activation of alternative transport and catabolic pathways of *S. mutans*, as well as other adaptive mechanisms in response to environmental changes that enhance carbohydrate utilization (vs. single-species *S. mutans* biofilm). Such a scenario would also be consistent with activation of the PDH pathway, since *S. mutans* growing with excess carbohydrate predominantly shunt carbon through LDH. Notably, the inactivation of *pdh* impairs the survival of *S. mutans* in limiting sugar conditions in stationary phase ([@B17]), such that activation of *pdh* could be important for survival or persistence of *S. mutans* or a sub-population of *S. mutans* in the mixed-culture system employed here.

In addition to producing energy for growth and anabolic processes, the *pdh* operon has also been shown to be vital for survival of sugar-starved *S. mutans* ([@B17]) and its acid tolerance ([@B49]), which are critical virulence properties within cariogenic biofilms. When carbohydrates are in excess, the LDH enzyme is allosterically activated by fructose-1,6-biphosphate, a glycolytic intermediate, to catalyze the conversion of pyruvate to lactate via generating NAD^+^ from NADH (homolactic fermentation). Notably, LDH would be less active in carbohydrate-limiting conditions and utilization of galactose via the tagatose pathway (which is activated in dual-species) bypasses the production of the intermediates that regulate carbohydrate regulation (F-1,6-bP, G-6-P) ([@B84]). However, in carbohydrate-liming conditions, the metabolic shift between pyruvate and formate is controlled by PFL, which can convert pyruvate to formate and acetyl-CoA via up-regulated pyruvate metabolism (heterolactic fermentation). Acetyl-CoA can be further converted to acetyl-phosphate (acetyl-P), which can be used for the production of ATP via acetate kinase. Importantly, PFL appears to have a key role in pyruvate metabolism of *S. mutans* residing within natural dental biofilm ([@B1]).

We detected higher concentrations of extracellular formate in dual-species biofilms (∼five-fold increase vs. single-species) as determined via ^1^H-NMR (*P* \< 0.001, **Figure [2B-b2](#F2){ref-type="fig"}**), which was consistent with the increased expression of the genes for PFL. In contrast, *ldh* expression between dual-species and single-species *S. mutans* biofilms was unaffected and similar amounts of lactate were found in the culture medium (**Figure [2B-b2](#F2){ref-type="fig"}**). Formate, a stronger acid (pKa = 3.75 vs. pKa of lactate = 3.86), has been detected in significant amounts in resting cariogenic plaque in humans ([@B25]). Thus, induction of *S. mutans* PDH and PFL by the fungal presence within biofilms may contribute to the enhanced cariogenicity observed *in vivo* ([@B27]). Enhanced sugar metabolism induced by co-culturing of *C. albicans* combined with transcriptomic changes in PDH and PFL may offer at least one explanation for the carbohydrate limitation (**Figure [2](#F2){ref-type="fig"}**) and the observed gene expression patterns in dual-species biofilms. Moreover, PFL is inactivated by oxygen, whereas PDH production is enhanced by growth in air. The up-regulation of PDH and PFL pathways also suggest the potential for complex and spatially heterogeneous gene expression patterns, whereby cells are carbohydrate-limited, but differences in exposure of cells within certain regions of the biofilm may influence whether the PFL pathway (anaerobic) is active or cells predominantly use PDH (aerobic) to favor acetate production and generation of additional ATP.

*C. albicans* Can also Promote *S. mutans* Fitness and Virulence through Signal Transduction System
---------------------------------------------------------------------------------------------------

Two-component signal transduction systems (TCSTS) involve phosphotransfer events between transmembrane sensor kinases and cytoplasmic response regulators, which are transcription factors that bind DNA to repress and/or activate gene expression ([@B70]). Currently, 14 TCSTS have been identified that are able to enhance the ecological fitness and cariogenic potential of *S. mutans* ([@B68]). Genes encoding CiaRH \[i.e., *ciaR* (SMU_1129) and *ciaH* (SMU_1128)\] were up-regulated in the presence of *C. albicans* (two-fold), and this system has been implicated in acid tolerance, sucrose-dependent adherence and biofilm formation by *S. mutans* ([@B61]; [@B3]; [@B10]). Although in a different bacterial-fungal biofilm system, [@B26] also observed that *ciaR* gene in *S. gordonii* was up-regulated in early-stage of interaction with *C. albicans.* The gene *comC* (SMU_1915) encoding competence stimulating peptide (CSP), as well as several late competence genes, including *comYB* (SMU_1985), *comYD* (SMU_1983), *comEA* (SMU_625), and *comEC* (SMU_626) were down-regulated \[log~2~ (fold change) \< -0.7\]. Factors regulating the development of genetic competence have been shown to influence acid tolerance, biofilm formation, eDNA release and stress tolerance in general. In parallel, a recent microfluidic study revealed that CSP signaling to induce competence is highly sensitive to pH and can be turned-off even in mildly acidic conditions (\<pH 6.0, [@B69]). Thus, biofilm microenvironmental changes may down-regulate genes involved with the development of genetic competence.

Other Potential Interactions between *S. mutans* and *C. albicans*
------------------------------------------------------------------

Another notable difference between mono- and dual-species biofilms was the marked down-regulation of genes associated with the production of a suite of small antimicrobial peptides (bacteriocins) termed mutacins by *S. mutans* when co-cultured with *C. albicans* (**Table [2](#T2){ref-type="table"}** and Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Since the expression of mutacin genes, which is regulated mainly by the CSP-ComDE system, is considered to be important in the competition with early colonizers, including *S. sanguinis* and *S. gordonii* ([@B54]), a less robust activation of mutacin gene expression in *S. mutans* could alter the microbial composition of oral biofilms in a way that promotes a symbiotic relationship between *S. mutans* and *C. albicans*. Furthermore, previous studies reveal that deletion of genes \[*nlmA* (SMU_150) and *nlmB* (SMU_151)\] encoding mutacins IV and V in *S. mutans* results in lower antimicrobial activity against *S. pyogenes* ([@B33]; [@B35]), so decreased mutacin gene expression has indeed been correlated with lower mutacin biological activity.

We observed significant down-regulation of *comC*, the precursor for competence-stimulating peptide (CSP) that is a direct activator of mutacins via ComDE ([@B76]). It was previous shown that *C. albicans* activated *S. mutans comS* and *sigX* ([@B71]), so the down-regulation of *comC* might be perceived as inconsistent with this previous study. However, ComCDE do not directly activate *comS* or *sigX* (*comX*). Indeed, the observed decrease of *comC* (the CSP precursor structure gene) expression is completely consistent with the fact that SMU_1914c, SMU_299c, SMU_1889c, SMU_423, SMU_150, and SMU_151, which encode bacteriocins or products required for bacteriocin production, were also down-regulated. Bacteriocin production is dominantly regulated by CSP, which acts directly through the ComDE TCS to activate bacteriocin gene expression ([@B76]). Previous studies showed that CSP can regulate *C. albicans* growth and morphogenesis ([@B37]). It is possible that *Candida*, in addition to promoting an acidic microenvironment, can produce several proteases that may inhibit CSP signaling system, similar to the inhibition of *S. mutans* bacteriocin production by *S. gordonii* challisin ([@B77]). Hence, the presence of *C. albicans* and its effects on the biofilm milieu could subvert mutacin production to enhance its own persistence. Of note, the low pH created by the combination of *C. albicans* and *S. mutans* may diminish the need for *S. mutans* to produce bacteriocins that mainly target comparatively acid-sensitive commensal streptococci.

We also detected genes associated with clusters of regularly interspaced short palindromic repeats (CRISPRs, i.e., SMU_1760c, SMU_1761c, and SMU_1762c) of *S. mutans* that were down-regulated in dual-species biofilms. Lack of CRISPR activity could be a direct reflection of decreased competence observed in mixed-species biofilms, which would decrease the amount of DNA being internalized by *S. mutans*. CRISPR are involved primarily in antiviral defenses in prokaryotes ([@B14]). However, the role of *S. mutans* CRISPR in caries development or in *C. albicans*--*S. mutans* interactions is presently unknown, but may warrant further investigation if the change in CRISPR expression does reflect some response to the presence of fungi.

In summary, the present study provides a comprehensive insight into *S. mutans* transcriptomic changes associated with the presence of *C. albicans* within mixed-species biofilm. GO term and KEGG pathway impact analysis support an active influence on *S. mutans* at the transcriptional level. The fungal presence modulates the expression of genes involved in *S. mutans* sugar metabolism, fitness and survival within biofilms, offering plausible explanations for the enhanced bacterial accumulation and virulence of the bacterial-fungal biofilms in the context of ECC (**Figure [6](#F6){ref-type="fig"}**). RNA-Seq provides a detailed 'snapshot' of the overall transcriptome changes, but there are limitations. For example, RNA-Seq provide an average gene expression profile at a given time-point without taking into consideration the substantial spatio-temporal heterogeneity that exists within complex biofilms. Nevertheless, future studies using specific mutants of *S. mutans* can now be designed based on the RNA-Seq data with the goal of comparing the behaviors of the strains to interact and persist in co-culture system. This will include testing different mutant strains with altered abilities in carbohydrate metabolism and/or respond to changes in the environment caused by *C. albicans* presence, including CcpA as well as mutacin production (*nlmAB*) and cell--cell communication (*comDE*). Furthermore, future studies using recently developed single-cell *in situ* RNA-Seq ([@B52]) and a bacterial--fungal nanoculture system ([@B43]) for localized gene expression may facilitate description of the spatio-temporal transcriptome patterns within biofilms.

![A snapshot of some of the transcriptome changes in *S. mutans* when co-cultured with *C. albicans*. Overall, the data reveal that the presence of *C. albicans* enhances sugar metabolism and metabolic fitness, and alters competence gene expression in *S. mutans*. **(A)** Up-regulation of the *scrA* gene encoding a high-affinity sucrose PTS permease (EII^Scr^) and possibly in concert with the product of the *pttB* gene encoding the trehalose-PTS (EII^Tre^) facilitates internalization of sucrose as sucrose-6-phosphate, with the glucose moiety carrying the phosphate group. Glucose-6-phosphate and fructose are produced via the action of ScrB, and ScrK used ATP to convert the fructose to fructose-6-phosphate. Both of these phosphohexoses can enter the glycolytic pathway. When *S. mutans* is growing in the presence of *C. albicans*, pyruvate metabolism can be affected by the availability of glycolytic intermediates. **(B)** The presence of *C. albicans* also appears to up-regulate the production of the CiaRH two component signal transduction system (TCSTS), which modulates acid tolerance, sucrose-dependent adherence and biofilm formation in *S. mutans*. **(C)** Another signaling system in *S. mutans*, the CSP-ComDE pathway, is affected by *C. albicans*. ComC (▲) is secreted and processed by ComAB to produce CSP (see text for more detail) and this peptide is then detected by the ComDE TCSTS. ComE directly activates bacteriocin production and CSP indirectly stimulates the development of genetic competence, as well as influencing cell. Indeed, changes of CSP-comDE pathway via down-regulation of *comC* can lead to down-regulation of downstream bacteriocin genes (e.g., *nlmAB*) and decreases in expression of late competence genes (*comYABCD*). Red letters indicate up-regulated genes, blue letters show down-regulated genes.](fmicb-08-01036-g006){#F6}

Although we focus on the influence of the presence of *C. albicans* on *S. mutans* transcriptome, *S. mutans* also provides benefits to *C. albicans*, such as enhanced colonization on the tooth surface and cross-feeding sucrose break-down products (e.g., glucose) for fungal utilization. Conversely, *S. mutans* could also impact *C. albicans* transcriptome based on recent observations that *S. gordonii* activate fungal genes associated with filamentation and proteases ([@B26]). We are optimizing a protocol for both bacterial and fungal mRNA enrichment from mixed-species biofilms for dual RNA-Seq studies, which combined with metaproteomics, may provide additional mechanistic explanations. Clearly, this bacterium--fungus interaction is complex and multifaceted, and could induce additional cross-kingdom responses and alter the surrounding biofilm microenvironment to modulate the cariogenic potential of biofilms. We are currently exploring how the fungal infection is acquired and how *Candida* responds to the presence of *S. mutans* in cariogenic biofilms. Enhanced colonization and increased carriage of *C. albicans* in plaque biofilms may also provide a fungal reservoir that could promote *Candida* infections of oral mucosal surfaces. Thus, inclusion of antifungals may be an important factor for devising more effective therapies to control ECC and its consequences.
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